dsm-firmenich Q1 2026 trading update

AI Briefing

• – dsm-firmenich reports solid Q1 2026 results with 4% LFL sales growth, driven by Perfumery & Beauty, and maintains FY 2026 outlook of 2-4% LFL sales growth, 20% adjusted EBITDA margin
• – Perfumery & Beauty delivers strong 8% LFL sales growth, driven by Perfumery & Beauty
• – Taste, Texture & Health delivers 3% volume-based LFL sales growth, driven by revenue synergies